25.4 C
Vientiane
Sunday, August 17, 2025
spot_img
Home Blog Page 173

SHEIN X TEAMS UP WITH HOUSE OF ONE FOR A CHIC, ACCESSIBLE CAPSULE COLLECTION

The Collection Features Polished Staples, Soft Tailoring, and Affordable Indulgence for Every Moment on Your Calendar

LOS ANGELES, July 28, 2025 /PRNewswire/ — SHEIN X, the collaboration platform under global fashion and lifestyle online retailer SHEIN, introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One. Designed for women who dress with intention, the SHEIN X HOUSE OF ONE collection delivers timeless pieces that balance sophistication, comfort, and quiet confidence – all at accessible price points.

SHEIN X introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One.
SHEIN X introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One.

Featuring clean lines, soft tailoring, and thoughtful details like pleats, piped edges, and cinched waists, the 50-piece collection offers refined wardrobe staples made to meet the moment – whether it’s a Monday meeting, an after-hours event, or a well-earned day of rest. House of One’s signature aesthetic – feminine, flattering, and quietly confident – is reimagined through SHEIN’s lens of global accessibility and innovation.

“This collection embodies our belief that clothing should feel like a reward – elevated but never fussy,” said Ronaldo Engelbrecht, Lead Designer House of One. “Our goal was to create pieces that bring ease and elegance to everyday life, helping women feel composed, confident, and fully themselves. Collaborating with SHEIN X gave us the platform to share that message on a global scale, combining thoughtful design with incredible reach.”

Rooted in a palette of warm creams, charcoals, camel, and soft blue, the collection draws inspiration from heritage minimalism and everyday grace. Structured silhouettes are softened by draped fabrics and breathable knits, while linen blends offer tactile richness that wears beautifully over time. From wide-leg trousers and tailored sets to softly pleated skirts and refined day-to-night dresses, each piece is designed to move with real life – and feel like a moment of indulgence in the middle of it.

Made for the woman who dresses with purpose and shops with care, SHEIN X HOUSE OF ONE invites customers to experience what House of One calls affordable indulgence: timeless design that feels expensive – without the price tag.

Prices range from $9.29 to $48.39. The collection is available now, exclusively on SHEIN. Share your favorite looks using #SHEINXHouseofOne, and keep an eye out for future collaborations between SHEIN X and House of One.

 About SHEIN X: 

SHEIN X is a program under SHEIN – the global fashion and lifestyle online retailer – that collaborates with designers and creators to launch exclusive collections. Each release showcases the originality of talented creators worldwide and marries the essence of upscale fashion with affordability, giving a designer touch to all styles. To learn about SHEIN X, visit https://us.shein.com/campaigns/sheinxcollabs

About SHEIN: 

SHEIN is a global fashion and lifestyle online retailer, offering SHEIN branded apparel and products from a global network of vendors, all at affordable prices. Headquartered in Singapore, SHEIN remains committed to making the beauty of fashion accessible to all, promoting its industry-leading, on-demand production methodology for a smarter, future-ready industry. To learn more about SHEIN, visit www.sheingroup.com

 About House of One:

House of One is a modern womenswear label born from quiet strength and everyday grace—where refined tailoring meets feminine ease. Designed for the woman who leads with purpose and dresses with intention, our pieces reflect the rhythm of real life: full days, layered roles, and moments of pause in between. We believe clothing should offer more than function—it should offer a feeling. A sense of calm, capability, and quiet confidence. Each piece is crafted to flatter without effort, combining structured silhouettes with soft draping, subtle detail, and a touch of indulgence. For more information, visit https://houseofoneofficial.com/.

Press Contacts:

Kate Fosha George
kate.fosha@sheingroup.com 

Alyssa McDonald
amcdonald@sheingroup.com

DP WORLD SMART LOGISTICS NETWORK DELIVERS McLAREN RACING CAR TO FANS IN TRAFALGAR SQUARE

From Pit Lane to Piccadilly: World Endurance Championship (WEC) 2027 show car delivered from the circuit des 24 Heures du Mans to the F1 team’s McLaren Technology Centre for fan festival. Two destinations, 633 kilometres, one channel crossing – all in four days through the power of smart logistics

LONDON, July 28, 2025 /PRNewswire/ — Global logistics leader DP World and the McLaren F1 Team joined forces to deliver a feat of logistics and an unforgettable fan experience in London during the British Grand Prix week.

WEC show car on display at Trafalgar Square.
WEC show car on display at Trafalgar Square.

In a bold demonstration of the power of smart logistics, DP World orchestrated the time-critical delivery of McLaren Racing’s newly unveiled WEC 2027 show car from the Circuit de 24 Heures du Mans in France, to the McLaren Technology Centre in Woking, before the car made its way to the first ever Racing Live: London event in Trafalgar Square.

Stephen Whittingham, Executive Vice President, North Europe, at DP World, said: “The logistics operation was a test of precision and timing, which saw DP World deploy a bespoke, temperature-controlled glass container to ensure the safe and secure transit of McLaren Racing’s WEC show car under tight deadlines.”

“Leveraging our expansive European network, the move was executed seamlessly by our expert logistics teams, underscoring the company’s capabilities in supporting high-value, sensitive cargo for the automotive and motorsports industries.”

The WEC 2027 show car’s final destination, McLaren Racing Live: London, was set against the iconic backdrop of Trafalgar Square and brought the energy of Formula 1 to the Capital’s centre. As part of the fan experience, DP World partnered with the McLaren F1 Team to create the ‘Pit Stop Challenge’ using one of the McLaren Formula 1 Team show cars.

The challenge saw more than a thousand racing fans take up the chance to step into the shoes of a McLaren pit crew member and attempt a tyre change at the speed of a real F1 team. Queues stretched over an hour as fans eagerly awaited their chance to get hands-on with the dynamic show car of the current Constructors’ Championship leaders.

Follow DP World on:
X (Twitter): https://twitter.com/DP_World
LinkedIn: https://www.linkedin.com/company/dp-world

About DP World

DP World is reshaping the future of global trade to improve lives everywhere. Operating across six continents with a team of over 115,600 employees, we combine global infrastructure and local expertise to deliver seamless supply chain solutions. From Ports and Terminals to Marine Services, Logistics and Technology, we leverage innovation to create better ways to trade, minimizing disruptions from the factory floor to the customer’s door.

WE MAKE TRADE FLOW

Our partnerships

Our global sports partnerships in Golf, Cricket, Formula 1 and Sailing showcase our leadership in supply chain transformation. From delivering SailGP to supporting the ICC T20 Cricket World Cup and The Ryder Cup, DP World simplifies logistics, drives performance and changes what’s possible.

Our partnership with McLaren Racing
As the team’s Official Logistics Partner, our global reach and capabilities allow us to bridge the most complex supplier networks in Formula 1 and beyond. From next-generation blockchain technology to seamlessly connected multi-modal solutions, we consult with McLaren Racing to deliver efficiently and sustainably, so they’re always race-ready.

About McLaren Racing

McLaren Racing was founded by racing driver Bruce McLaren in 1963. The team entered its first Formula 1 race in 1966. McLaren has since won 21 Formula 1 world championships, 197 Formula 1 Grands Prix, the Indianapolis 500 three times, and the Le Mans 24 Hours at its first attempt.

McLaren Racing competes across five racing series. The team competes in the FIA Formula 1 World Championship with McLaren F1 drivers Lando Norris and Oscar Piastri, the NTT INDYCAR SERIES with Arrow McLaren drivers Pato O’Ward, Nolan Siegel and Christian Lundgaard, the ABB FIA Formula E World Championship as the NEOM McLaren Formula E Team with drivers Sam Bird and Taylor Barnard, and F1 Academy with Driver Development programme member Ella Lloyd. The team also competes in the F1 Sim Racing Championship as McLaren Shadow.

McLaren is a champion for sustainability in the sport and a signatory to the UN Sports for Climate Action Commitment. It is committed to achieving net zero by 2040 and fostering a diverse and inclusive culture in the motorsport industry. 

McLaren Racing – Official Website

For more insights into how DP World is reshaping global trade, visit our website: www.dpworld.com

 

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

NEW YORK, July 28, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

Ashley Mastronardi delivers the pre-market update on July 28th

  • Stocks are up Monday morning as the U.S struck a trade deal with the EU ahead of President Trump’s August 1st deadline. This deal comes after the U.S reached agreements with Japan and Indonesia last week.
  • The Federal Reserve will hold its next two-day policy meeting on Tuesday and Wednesday. The Central Bank is expected to keep interest rates unchanged, but investors will listen closely to Chair Jerome Powell’s comments.
  • Wall Street will be paying attention to earnings this week as Microsoft, Meta, Amazon and Apple will all report.

Opening Bell
Southside Bancshares (NYSE: SBSI) celebrates the 65th anniversary of Southside Bank

Closing Bell
Seaport Entertainment (NYSE: SEG) celebrates the company’s one-year anniversary

Click here to download the NYSE TV App

Video – https://mma.prnasia.com/media2/2739198/NYSE_Market_Update_July_28.mp4 

 

Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature’s Miracle (“NMHI”) Common Stocks

ONTARIO, Calif., July 28, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (NMHI) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology announce that Big Lake Capital, LLC (the “Investor”), an investment company led and controlled by CEO Tie “James” Li, converted $678,290 into 3,425,706 NMHI shares at a conversion price of $0.1980 pursuant to the Convertible Promissory Note signed on April 11, 2025, between the Company and Big Lake Capital.

Pursuant to the Convertible Promissory Note signed on April 11, 2025, the Investor is going to lend to the Company up to $2,000,000, with the initial tranche of $600,000 which was funded on April 11, 2025. Terms include an interest rate of 10% payable monthly and a term of one year. The Investor can choose to convert any amount funded plus accrued interest into shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) at a conversion price equal to $0.198 or 110% of the closing price of the Common Stock on April 11, 2025, the date of initial funding. 

Following the conversion, no amounts are outstanding under the note. The Company may borrow up to an additional amount of $1.342.428 under the note.

About Nature’s Miracle Holding Inc.

Nature’s Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (“CEA”) industry in the U.S. The Company’s Common Stock trades on the OTCQB market (“OTCQB”) under the symbol “NMHI”.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature’s Miracle’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature’s Miracle’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature’s Miracle’s ability to develop and launch new products and services; Nature’s Miracle’s ability to successfully and efficiently integrate future expansion plans and opportunities; Nature’s Miracle’s ability to grow its business in a cost-effective manner; Nature’s Miracle’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature’s Miracle’s business model; developments and projections relating to Nature’s Miracle’s competitors and industry; and Nature’s Miracle’s approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature’s Miracle’s operates; the risk that Nature’s Miracle’s and its current and future collaborators are unable to successfully develop and commercialize Nature’s Miracle’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature’s Miracle’s is unable to secure or protect its intellectual property; the possibility that Nature’s Miracle’s may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature’s Miracle’s filings from time to time with the SEC.

World’s First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market

SUZHOU, China, July 28, 2025 /PRNewswire/ — ImmVira Group (“ImmVira” or the “Company”)recently announced that its engineered exosome products MVR-EX104 (“EX104”, for alopecia treatment) and MVR-EX105 (“EX105”, for localized fat accumulation) have obtained International Nomenclature of Cosmetic Ingredients (INCI) designations following review by the International Cosmetic Ingredient Nomenclature Committee (INC). This dual milestone underscores ImmVira’s breakthrough leadership in functional aesthetic ingredients, bring forward revolutionary consumer healthcare solutions.

Leveraging proprietary OVPENS technology platform, ImmVira developed its engineered exosome portfolio—including MVR-EX103 for skin-related conditions (INCI name granted in April 2025), EX104 for alopecia treatment, and EX105 for localized fat accumulation—for direct commercialization with flexible registration pathways, targeting substantial aging-related market opportunities. Concurrently, on the clinical therapeutic front, our exosome candidates also deliver a novel treatment option for those chronic, hard-to-treat disease indications, such as wound healing and pulmonary fibrosis.

As the universal “passport” for aesthetic ingredients, INCI standards cover multiple major markets including the US, EU, and Japan. This certification validates ImmVira’s pioneering position in engineered exosome technology, enables direct overseas market entry, and enhances consumer trust through INCI’s mandated ingredient transparency.

Per Frost and Sullivan, global alopecia treatment and localized adipose accumulation management treatment markets will reach $89.9 billion and $191.5 billion respectively by 2033. Utilizing engineered exosome that co-delivers multi-functional proteins with designed precise efficacy and enhanced skin penetration, EX104 and EX105 enable deep cellular-level modulation through non-invasive topical use, reshaping traditional treatment paradigms.

“From skin repair (EX103) to hair regeneration (EX104) and localized fat reduction (EX105), our OVPENS platform demonstrates sustainable capacity for breakthrough healthcare innovations. ” stated Dr. Zhou Guoying, CEO of ImmVira. “Leveraging precision-engineered design and targeted delivery of multiplex functional proteins, we maintain a strategically balanced portfolio that directly targets high-value, aging-related market opportunities with strong business acumen. The platform’s inherent expandability allows us to rapidly develop new pipeline candidates to address specific indication needs, enabling novel treatment modalities that empower the public to achieve health and beauty.”

With this dual certification, ImmVira solidifies its role as the global industrial leader in engineered exosomes. ImmVira is accelerating development of a worldwide health and wellness product matrix spanning skin health, hair management and fat reduction, ushering in a new chapter for home-use professional-grade bioactive solutions.

About ImmVira

ImmVira is a global leading clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization of novel oncolytic immunotherapies and engineered exosome therapies. We have strategically designed and built a risk-balanced product portfolio that comprised both potentially best-in-class oncolytic immunotherapy candidates for solid tumors and innovative engineered exosome assets for clinical application or direct commercialization. Driven by our strategic priority to become a global leader in the full spectrum of bladder cancer treatment development, we have adopted a rationalized, adaptive approach to advance oncolytic immunotherapy candidates with high clinical potential globally. In parallel, leveraging our deep expertise in biological engineering, we have pioneered development of engineered exosome candidates targeting chronic, hard-to-treat diseases as well as age-related conditions. These selected engineered exosome assets are being deliberately accelerated through strategic, differentiated regulatory pathways to enable expedited commercialization and generate sustainable cash flows that will fuel our broader drug development efforts.

Railtown AI Technologies Inc. and AI Partnerships Corp. Partner with Braiyt AI Inc. to Bring Canadian AI Innovation to Dubai and the Middle East

Vancouver, British Columbia – Newsfile Corp. – July 28, 2025 – Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) (“Railtown” or the “Company”) a leader in Canadian-built artificial intelligence solutions, together with AI Partnerships Corp. (aipartnershipscorp.com), today announced a strategic joint partnership Braiyt AI Inc. (braiyt.ai) to deliver cutting-edge AI technologies to Dubai and the broader Middle East region.

This alliance marks a significant step in expanding the footprint of Canadian AI innovation into one of the world’s most dynamic and rapidly growing markets for artificial intelligence. Under the partnership, Braiyt AI Inc. will act as a regional consultant and service provider, representing Railtown and AIP across Dubai and the Gulf states.

“Braiyt has built a reputation as a trusted Canadian AI solutions provider in the Middle East,” said Cory Brandolini, CEO at Railtown AI Technologies. “Their insight into the regional market, combined with their strong local presence, makes them the ideal partner to help meet the increasing demand for advanced AI capabilities in the region.”

As Middle Eastern organizations continue to pursue digital transformation, the demand for specialized AI solutions has outpaced the capacity of homegrown providers. This partnership ensures that businesses and government agencies across the Gulf can access proven, scalable technologies developed by Canadian innovators.

“Our collaboration with Railtown and AI Partnerships allows us to bring best-in-class AI solutions into a market that is eager for growth and transformation,” said Warsame Ahmed, CEO of Braiyt AI Inc. “We’re proud to be the bridge that connects Canada’s innovation with the Middle East’s bold digital ambitions.”

“The relationship with Braiyt AI, in partnership with Railtown AI Technologies, opens the door and unites our shared vision and complementary strengths to deliver transformative AI solutions to the Middle East,” said Dr. Tom Corr, CEO of AI Partnerships Corp. “By integrating Railtown’s pioneering technology with our global network, we are co-creating a powerful platform for innovation, driving unparalleled value for businesses across diverse markets together.”

“This partnership also opens the door for future collaboration with other members of AI Partnerships Corp.’s growing global network of Affiliates who provide AI based solutions and tools addressing varies vertical market sectors,” said Dr. Tom Corr, CEO of AI Partnerships Corp. “This partnership is another notable example of the AI Partnerships Affiliates leveraging their technical strength and world-wide presence.”

About AI Partnerships Corp.

AI Partnerships Corp. is on a mission to make AI more accessible and affordable to businesses of all sizes. By leveraging the technology and expertise of its Affiliate Network-comprising over 150 AI solutions providers-AI Partnerships supports the mass adoption of enterprise AI globally. Learn more at www.aipartnershipscorp.com.

About Braiyt AI Inc.

Braiyt AI Inc. is a Canadian technology company specializing in delivering next-generation solutions in artificial intelligence, machine learning, and computer vision. Originally founded with a mission to reshape metrics in retail environments, BR[AI]YT has since expanded its capabilities across multiple industries.

The company supports both business and government clients in planning and executing effective AI implementation strategies-whether they’re just beginning their AI journey or enhancing existing capabilities. BR[AI]YT focuses on harnessing the transformative power of AI to create smarter, more efficient, and seamlessly connected physical spaces.

Through innovative, AI-powered solutions, BR[AI]YT aims to enhance operational efficiency, improve user experiences, and drive sustainable growth. With a strong presence in the Middle East and a growing reputation for excellence, BR[AI]YT is on a mission to become the leading force in AI-powered digital transformation in the region and beyond. Learn more at www.braiyt.ai.

About Railtown AI Technologies Inc.

Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) is a leader in developer productivity tools and agentic frameworks. Based in Vancouver, Canada, Railtown delivers solutions that streamline software development workflows, reduce downtime, and increase the speed of innovation for engineering teams worldwide. By embedding intelligence into every stage of the software lifecycle, Railtown is redefining how modern development teams work. Learn more at www.railtown.ai.

Follow us on social media


SUBSCRIBE FOR INVESTOR NEWS

Click here to receive our latest investor news alerts.

ON BEHALF OF THE BOARD

“Cory Brandolini”
Cory Brandolini, Chief Executive Officer

INVESTOR CONTACT

Rebecca Kerswell
Investor Relations Contact
Email: investors@railtown.ai
Phone: 1-604-417-4440

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will,” “may”, “should”, “intends”, “anticipates”, “expects” and similar expressions. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding the future plans and objectives of the Company, the commencement of trading of the Company’s common shares on the CSE, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulators.

Readers are cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, the Company cannot guarantee that any forward-looking statement will materialize, and readers should not place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward-looking statements as expressly required by Canadian securities law.

The issuer is solely responsible for the content of this announcement.

Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer’s Association International Conference (AAIC)

Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting

FREMONT, Calif., July 28, 2025 /PRNewswire/ — Alamar Biosciences, a company pioneering precision proteomics to drive the earliest detection of disease, today announced the presentation of NULISA™ data in over 30 scientific sessions and poster presentations at the AAIC conference held July 27-31 in Toronto, Canada. The NULISA platform is poised to redefine the landscape of biomarker detection, offering unprecedented sensitivity, specificity and multiplex detection for neurodegenerative disease diagnosis and monitoring. This year’s AAIC marks the first public presentation of robust clinical data generated using NULISA to measure brain-derived pTaus alongside over 120 key CNS disease-related proteins, an achievement that could accelerate both early detection and therapeutic monitoring in Alzheimer’s and related neurodegenerative conditions.

Alzheimer's Association International Conference 2025, Toronto, Canada, July 27-31, 2025.
Alzheimer’s Association International Conference 2025, Toronto, Canada, July 27-31, 2025.

“The presentation of brain-derived pTau data at AAIC is a testament to the power of the NULISA sensitivity and specificity and our team’s dedication to advancing biomarker development for neurodegenerative diseases,” said Yuling Luo, PhD, Founder, Chairman and CEO of Alamar Biosciences.

These data will be presented during Alamar’s product theater on Monday, July 28, 1:20 PM ET, featuring Prof. Jonathan Schott from University College London and the UK DRI, and Dr. Cheryl Wellington from the University of British Columbia. Highlights include:  

  • Brain-Derived pTau Performance: The presentation will showcase data from the 1946 Birth Cohort featuring the new brain-derived pTau isoforms using the NULISAseq™ CNS Disease Panel 120 in both presymptomatic and post-AD diagnosis samples, highlighting the superior ability of brain-derived pTaus to predict Alzheimer’s disease years before it was diagnosed
  • Correlations with Disease Progression: Data will demonstrate the correlation between brain-derived pTau levels and amyloid and Tau PET imaging
  • Biomarkers for neuropathologies and AD co-pathologies: Analysis of a unique cohort of patients with autopsy-confirmed pathologies with the NULISAseq™ CNS Disease Panel 120 identified biomarkers for detecting neuropathologies and AD co-pathologies.
  • Preclinical research: The NULISAseq™ Mouse Panel 120 demonstrated utility in analysis of plasma and brain homogenate samples from multiple clinical models of AD.

The Alzheimer’s Association International Conference (AAIC) is the world’s premier forum for the scientific community focused on dementia and Alzheimer’s research. Every year, the conference gathers leading experts, scientists, clinicians, and stakeholders to share the latest discoveries, foster collaborations, and accelerate the quest for effective diagnostics and therapies.

See here for a full list of posters and presentations featuring NULISA data during the AAIC meeting.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA Platform along with the ARGO HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

-

 

JAS signs SPA to acquire Pentagon Freight Services

ATLANTA, July 28, 2025 /PRNewswire/ — JAS, a global leader in logistics and supply chain solutions, and Pentagon Freight Services (“Pentagon”), a highly specialized integrated Freight Forwarding, Project Logistics and Ships Agency provider headquartered in the UK, are pleased to announce the signing of a Share Purchase Agreement (SPA). This agreement represents a key step toward JAS’s planned acquisition of Pentagon, which is expected to close in the second half of 2025, subject to regulatory approval.

From left, Marco Rebuffi, CEO and President of JAS, and Ashley Taylor, Group CEO of Pentagon.
From left, Marco Rebuffi, CEO and President of JAS, and Ashley Taylor, Group CEO of Pentagon.

“The Pentagon acquisition perfectly complements JAS’s strategic goals, significantly increasing our ability to offer highly specialized logistics solutions for the oil and gas, marine, construction, and energy industries. We are looking forward to finalizing this acquisition to welcome Pentagon team members into the JAS family,” said Marco Rebuffi, CEO and President of JAS. 

“We are confident that JAS is the right company to expand our global network and achieve our growth ambitions. Our goal is to leverage our experience and continue to offer dedicated logistics solutions to our industry-leading clients. We look forward to growing stronger together with JAS,” said Ashley Taylor, Group CEO of Pentagon.

Pentagon, headquartered in the UK, is a trusted provider of specialized freight forwarding, project logistics, and critical supply chain solutions for the oil and gas, energy, marine, and construction industries. With over 1200+ employees in 65 offices around the world, Pentagon’s deep expertise and global reach will further enhance JAS’s ability to deliver tailored, industry-specific solutions. This acquisition will strengthen JAS’s position in these critical sectors, ensuring seamless and high-quality service that keeps complex customer operations moving across the globe.

Together, JAS and Pentagon will unlock new opportunities and deliver even greater value to customers by combining an expanded global network with a comprehensive portfolio of leading logistics solutions.

About JAS
JAS, a global leader in logistics and supply chain solutions, was founded in Milan, Italy, in 1978. Headquartered in Atlanta, Georgia, and supported by 7,000+ team members in more than 100 countries, JAS focuses on creating solutions that are innovative, sustainable, and tailored to customer needs. As a privately owned company, JAS is committed to creating opportunities for communities, customers, and colleagues to thrive.

About Pentagon
Pentagon is a highly specialized global Freight Forwarding, Project Logistics and Ships Agency provider with a worldwide network of over 1200 employees and 65 offices. Headquartered in the UK, Pentagon has more than 50 years’ experience in serving the oil and gas and energy sectors. Pentagon focuses on delivering globally integrated supply chain solutions with local expertise, individually tailored to customers’ operations and requirements.